• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Microbes and Infectious Diseases
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 3 (2022)
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2021)
Volume Volume 1 (2020)
Erfan, D., Ibrahim, W. (2022). Evaluation of direct Carba-NP (CNPt) for screening of carbaenemases production in Gram negative bacilli. Microbes and Infectious Diseases, 3(2), 378-386. doi: 10.21608/mid.2022.119218.1243
Dina Erfan; Walaa Ibrahim. "Evaluation of direct Carba-NP (CNPt) for screening of carbaenemases production in Gram negative bacilli". Microbes and Infectious Diseases, 3, 2, 2022, 378-386. doi: 10.21608/mid.2022.119218.1243
Erfan, D., Ibrahim, W. (2022). 'Evaluation of direct Carba-NP (CNPt) for screening of carbaenemases production in Gram negative bacilli', Microbes and Infectious Diseases, 3(2), pp. 378-386. doi: 10.21608/mid.2022.119218.1243
Erfan, D., Ibrahim, W. Evaluation of direct Carba-NP (CNPt) for screening of carbaenemases production in Gram negative bacilli. Microbes and Infectious Diseases, 2022; 3(2): 378-386. doi: 10.21608/mid.2022.119218.1243

Evaluation of direct Carba-NP (CNPt) for screening of carbaenemases production in Gram negative bacilli

Article 17, Volume 3, Issue 2, May 2022, Page 378-386  XML PDF (347.29 K)
Document Type: Original Article
DOI: 10.21608/mid.2022.119218.1243
Authors
Dina Erfan email orcid ; Walaa Ibrahimorcid
Medical Microbiology and Immunology Department, Faculty of medicine, Ain Shams University, Egypt
Abstract
Background: Carbapenem resistance among gram negative bacilli (GNB) is a major threat to human health. Rapid and accurate detection of carbapenemase production is very important for clinical management, epidemiological purposes and infection prevention and control issues. Direct Carba NP test (CNPt) is a modified CNPt that allows rapid detection of carbapenemases at a lower cost and improved sensitivity. This work aimed to evaluate direct-CNPt for detection of cabapenemases production as a screening and confirmatory test in GNB versus multiplex PCR as the gold standard test. Methods: This study was conducted on 50 clinical isolates of GNB derived from different clinical samples according to their resistance to meropenem (zone of inhibition ≤ 23 mm). Direct CNPt was performed on all 50 clinical isolates using bacterial colonies directly. A change in colour was observed after (̰ 2 h). A multiplex PCR was performed on all isolates to detect bla KPC, bla IMP, bla VIM and bla NDM, and bla OXA-48 genes. Results: The overall sensitivity and specificity of direct CNPt as compared to multiplex PCR were 95.2% and 100% respectively. The sensitivity to OXA-48 and IMP genes were relatively lower (91.6 % and 85.7 % respectively) than other genes which had 100% sensitivity for each. Conclusion: Direct CNPt is a reliable and rapid method that allows detection of different carbapenemases at a reduced cost. It could be used in combination with other phenotypic or genotypic assays in settings where OXA-48 and IMP are of high prevalence.
Keywords
Carba NP test; phenotypic assay; carbapenemase; real time PCR
Main Subjects
Antimicrobial resistance
Statistics
Article View: 86
PDF Download: 70
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.